🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Chambers-Spakowicz Dan Spakowicz labs seek a motivated postdoc to join a team studying the microbiome and chemo/IO treatment responses in gynecologic cancers at the Pelotonia Institute for Immuno-Oncology and The James! OSUGYNONC go.osu.edu/microbiome-pos…

Thrilled to share our work supporting that disruption of the #gutmicrobiome impacts platinum chemotherapy response in #ovariancancer just published in Cancer Research. Such an important, collaborative effort Ofer Reizes Chad Michener, MD Roberto Vargas, MD Cleveland Clinic Lerner Research Institute.

An intact #microbiome functions as a tumor suppressor in #OvarianCancer, and antibiotics perturb gut microbiota to promote tumor growth and suppress cisplatin sensitivity. bit.ly/3O1Kr8s Ofer Reizes Laura Chambers The Ohio State University Wexner Medical Center

Join me in attending The GOG Foundation, Inc. Dinner Meeting on Thursday, January 26th from 6:30 pm – 9:30 pm ET. For more information on this event for participating sites, go to gog.org/event/the-gog-……. #clinicaltrials #GynecologicOncology #GOGPartners #GOGF The GOG Foundation Inc. NRG Oncology

My amazing partner Kristin Bixel giving updates on ROCC trial Mario M. Leitao, Jr The James OSUGYNONC NRG Oncology David OMalley

Dr O'Malley David OMalley discussing the exciting GOG/NRG portfolio on ovarian cancer clinical trials NRG Oncology The James

AddThis | Home authors.elsevier.com/sd/article/S00… Now part of NCCN guidelines for PROC. Earlier opportunity to gain access for patients in patients with PSOC (GOG 3078; GLORIOSA). The James The GOG Foundation Inc..

Excellent presentation by Dr Molly Morton on the importance of clinical trials. Trial patients do better and live longer. SGO #swedishcancerinstitute

Excellent opening session presentation by OSUGYNONC fellow Molly Morton on improved OS with clinical trial participation in platinum resistant OC SGO Cleveland Clinic OB/GYN Residency

The modified 5-item frailty index is a predictor of post-operative complications in #VulvarCancer Laura Chambers Kristin Bixel 🔗bit.ly/3KpW9Z8 Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc

Proud of this important work by Molly Morton The James “More than a song and dance”: Exploration of patient perspectives and ... sciencedirect.com/science/articl…

A labor of love (and physiology) with Laura Chambers The James Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer sciencedirect.com/science/articl…

Thank you to The Green Journal, Laura Chambers for supporting this project - clinical trials improve outcomes for our patients! pubmed.ncbi.nlm.nih.gov/37535957/

Thanks @GynOncJnls for helping us share our work! Laura Chambers Prevalence of type 2 diabetes diagnoses in the perioperative and survi... sciencedirect.com/science/articl…

Type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer Molly Morton MD Laura Chambers SGO IGCS ESGO ASCO OncoAlert sciencedirect.com/science/articl…

#Editorial The inclusion of patient perspectives & timely management of toxicity in these guidelines should be applauded 👏 👏 By Molly Morton MD 🔗 bit.ly/3P0VNe1 Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO OncoAlert IJGC Fellows

Excited to share our work about impact of antibiotics and PPI on endometrial cancer patients Dan Spakowicz David OMalley The James

Excited to have many clinical trial opportunities for our patients and proud to be leading accrual for GOG foundation trials nationally The James OSUGYNONC #NRG2024 #GOGF #GOGPARTNERS

Had a great time the other evening with my incredible partnersat The James - Floor Backes and Laura Chambers discussing the incredible advances in our care of patients with gynecological malignancies OncLive.com #SOSS

From poo to promise: Fecal microbiota transplants support immunotherapy resensitization in solid tumors Laura Chambers Dennis Grencewicz Dan Spakowicz highlight work showing FMT improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers cell.com/cell-host-micr…